Spyre Therapeutics (SYRE) shares outstanding

Shares outstanding · fiscal 2025
64.06M

Spyre Therapeutics (SYRE) had 64.06M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 36.2% higher than the 47.03M of fiscal 2024. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
64.06M
Change on fiscal 2024
+36.2%
Growth, 5 years
+97.4% a year
Highest on record
64.06Mfiscal 2025
Lowest on record
2.13Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Spyre Therapeutics shares outstanding, in more detail

The market data feed counts 94.97M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 97.4% a year. Across the 6 fiscal years on record (2020–2025), the highest was 64.06M in fiscal 2025 and the lowest 2.13M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Spyre Therapeutics shares outstanding, year by year

Spyre Therapeutics (SYRE) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
202564.06M 36.2% up
202447.03M 581.9% up
20236.90M 104.6% up
20223.37M 28.2% up
20212.63M 23.2% up
20202.13M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Spyre Therapeutics and comparable companies
CompanyShares outstandingFiscal year
Vaxcyte PCVX136.09M2025
Bio-Rad Laboratories BIO27.28M2025
Molina Healthcare MOH52.90M2025
Spyre Therapeutics SYRE64.06M2025
Qiagen QGEN207.94M2025
Insulet PODD71.89M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on SYRE

Spyre Therapeutics, figure by figure

Spyre Therapeutics (SYRE) overview: price, valuation and scorecardAll health care companies by market value

Spyre Therapeutics shares outstanding: questions and answers

How many shares does Spyre Therapeutics have?

Spyre Therapeutics (SYRE) had 64.06M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 36.2% higher than the 47.03M of fiscal 2024. The market data feed counts 94.97M shares outstanding today.

What is the growth rate of Spyre Therapeutics's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 97.4% a year.

What are the highest and lowest diluted share count figures on record for Spyre Therapeutics?

Across the 6 fiscal years on record (2020–2025), the highest was 64.06M in fiscal 2025 and the lowest 2.13M in fiscal 2020.

How is Spyre Therapeutics's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Spyre Therapeutics it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Spyre Therapeutics (SYRE) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/SYRE/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.